Núria Reig
Hoofd Techniek/Wetenschap/O&O bij SOM Innovation Biotech SA
Actieve functies van Núria Reig
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
SOM Innovation Biotech SA
 SOM Innovation Biotech SA Pharmaceuticals: MajorHealth Technology SOM Innovation Biotech SA engages in the discovery and development of new indications for known drugs. Its pipeline consists of repositioned compounds for the treatment of amyloidosis, huntington's disease, hyperplasia, glioblastoma, and alzheimer's disease. The company was founded by Raul Insa Boronat and Ignasi Belda Reig on December 30, 2009 and is headquartered in Barcelona, Spain. | Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Núria Reig
Eerdere bekende functies van Núria Reig
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| EPFL Plus | Corporate Officer/Principal | - | - |
| Yale University | Corporate Officer/Principal | - | - |
| University of Geneva | Corporate Officer/Principal | - | - |
Opleiding van Núria Reig
| University of Barcelona | Doctorate Degree |
Statistieken
Internationaal
| Zwitserland | 3 |
| Spanje | 3 |
| Verenigde Staten | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
SOM Innovation Biotech SA
SOM Innovation Biotech SA Pharmaceuticals: MajorHealth Technology SOM Innovation Biotech SA engages in the discovery and development of new indications for known drugs. Its pipeline consists of repositioned compounds for the treatment of amyloidosis, huntington's disease, hyperplasia, glioblastoma, and alzheimer's disease. The company was founded by Raul Insa Boronat and Ignasi Belda Reig on December 30, 2009 and is headquartered in Barcelona, Spain. | Health Technology |
| EPFL Plus |
- Beurs
- Insiders
- Núria Reig
- Ervaring
